BOLDSCIENCE’s Post

Read our recent blog post by a veteran in drug discovery, about the early drug discovery process

Will you be in Dubrovnik for the NEXT Pharma Summit on 14 and 15 May? I'll be taking the stage to speak about #digitaltransformation in #pharma. During the session, I’ll talk about various use cases enabled by #ConversationalExperiences and #GenerativeAi. Hope to see you there! More information about the summit here: https://lnkd.in/ev-CrZkJ

Inotiv offers expert PK, TK, and PD services with rapid turnaround for all drug development stages. Leverage the experience of industry-trained scientists in all stages of drug discovery, from target ID to new drug application (NDA). Download our infographic to learn more. https://hubs.ly/Q02k4z7v0 #Inotiv #DMPK #Pharmacokinetics #Toxicokinetics #Pharmacodynamics

💊 𝐋𝐨𝐰 𝐢𝐧 𝐒𝐭𝐨𝐜𝐤 𝐑𝐞𝐟𝐞𝐫𝐞𝐧𝐜𝐞 𝐒𝐭𝐚𝐧𝐝𝐚𝐫𝐝𝐬! 🛒   🧪 In early drug development, researchers deal with some challenges. Don't let the fast and easy access to licensed molecules be one of them.   If you're in need of small units from licensed drugs, we've got you covered. Take a look at our current selection of rare drug aliquots and see if any of our unique batches align with your research project. 📦💊   We encourage you to act quickly before they sell out completely. Check our online shop link in the comments! 🛒🔬   #InnovationInMedicine #ResearchAndDevelopment #ClinicalGradeMolecules #Evidentic #Antibody #mAb #ClinicalGrade #DrugDevelopment #DrugDiscovery

Updated: Industry insiders love to say biotechs are bought, not sold. In the case of Eli Lilly's $3.2 billion deal for Morphic Therapeutic, the Indianapolis pharma giant approached the Boston biotech and outbid itself, according to a Friday morning SEC document. Another SEC filing outlined that Morphic reached out to at least two other companies but didn't receive bids from them. The nearly decade-old Morphic has had pharma interest over the years, with its Series A in 2016 including support from the corporate VC arms of a few large drugmakers, and it had partnerships over the years. Lilly wants access to an experimental IBD medicine that could potentially compete with Takeda's Entyvio blockbuster one day. Analysts think Morphic's oral drug could surpass $2 billion in peak sales, if it clears ongoing Phase 2 studies and later clinical trials. More on the behind-the-scenes of Lilly's first biotech consummation of 2024: Note: This story was updated to correct that Morphic reached out to at least two other companies during the discussions, based on another SEC filing from Friday morning. #biotech #pharma #manda #acquisition #dealbackgrounder #mergersandacquisitions #morphic #lilly #elililly

Discover the Future of BioPharma at the 19th BioPharma Drug Discovery Nexus in Basel! Join us on April 25-26 for cutting-edge insights and innovations in the heart of the Europe. Don't miss this exceptional gathering of pioneers in the BioPharma industry. Register now nexus-conference.com/ddneu #BioPharmaNexus #DrugDiscovery #NEXUSconference #DrugDiscovery #InnovationInPharma #PrecisionMedicine #TherapeuticAdvancements #PharmaResearch #BiotechInnovations #DrugDevelopment #ScientificBreakthroughs #ResearchCollaboration #FutureOfMedicine #PharmaTech #MolecularResearch #Bioinformatics #DrugDesign #TherapeuticTargets #PharmacologyInsights #MedChem #GenomicMedicine #TranslationalResearch #BioscienceInnovation #PrecisionTherapeutics #AIinDrugDiscovery #PharmaConference #BiotechEvent #ClinicalResearch #Pharmacogenomics #TargetedTherapies #DrugSafety #EmergingTechnologies #PharmaTrends #BiomedicalScience #Chemoinformatics #DrugDelivery #Immunotherapy #DiseaseModeling #MedicinalChemistry #DrugInnovation #PharmaLeadership #Biopharmaceuticals #CellTherapy #PatientCentricity #RegulatoryAffairs #DrugPipeline #PharmaSolutions #DrugFormulation #NextGenTherapeutics #PharmaNetworking #LabAutomation #DrugScreening #HealthcareInnovations #TherapeuticDiscovery #PharmaFutures

Come learn about our microbial and mammalian CDMO capabilities!

🦅 You have 7 hours left to secure $400 off your ticket to #AIDrugDiscoveryUSA: https://ow.ly/L1PM50SrS7G! 🦅 What if attending our conference could reveal how #AI is revolutionizing pre-clinical drug discovery, cutting costs by up to 40%, and creating a $50 billion market in the next decade? 🖱️ Fortunately for you, the AI in Drug Discovery USA Conference is the perfect opportunity to uncover the latest AI advancements in the #pharmaceutical R&D sector directly from experts, and gain strategies to support your operations. 🖱️ #AIinDrugs #PharmaInnovation #conference #SAEMGPharma #InnovateWithAI #DrugDiscoveryTech #FutureOfMedicine #PrecisionMedicineAI

FDA raises questions about Lilly’s Alzheimer’s drug; Adcomm votes against MDMA therapy; Inside Walmart Health’s challenges; and more https://lnkd.in/g_NNtQbM Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up [...] #LosAngeles #OrangeCountyCA #Biotech #Lifescience #News

🦅 You have 7 hours left to secure $400 off your ticket to #AIDrugDiscoveryUSA: https://ow.ly/L1PM50SrS7G! 🦅 What if attending our conference could reveal how #AI is revolutionizing pre-clinical drug discovery, cutting costs by up to 40%, and creating a $50 billion market in the next decade? 🖱️ Fortunately for you, the AI in Drug Discovery USA Conference is the perfect opportunity to uncover the latest AI advancements in the #pharmaceutical R&D sector directly from experts, and gain strategies to support your operations. 🖱️ #AIinDrugs #PharmaInnovation #conference #SAEMGPharma #InnovateWithAI #DrugDiscoveryTech #FutureOfMedicine #PrecisionMedicineAI